Experience

MC2 Therapeutics

• Denmark
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Exec. Director Business Development

  • Aug 2023 - Present

  Hørsholm, Capital Region, Denmark



Cereno Scientific

• Sweden
• Biotechnology
• 1 - 100 Employee

• Chief Business Officer

  • Mar 2023 - Jul 2023

  Gothenburg, Vastra Gotaland County, Sweden



Cessatech A/S

• Denmark
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Director Business Development

  • Jan 2022 - Feb 2023

  Copenhagen, Capital Region, Denmark Responsible for Business Development, FP&A, IR planning and communication



Genioo

• Switzerland
• Business Consulting and Services
• 1 - 100 Employee

• Business Development, FP&A and Commercial Planning

  • Sep 2021 - Dec 2021

  København, Hovedstaden, Danmark



Healthcare DENMARK

• Denmark
• Hospitals and Health Care
• 1 - 100 Employee

• Deputy Director (Vicedirektør)

  • Oct 2018 - Aug 2021

  Copenhagen, Denmark Head of Healthcare DENMARK Life Science A public-private partnership with the mandate to promote Danish Life Science strongholds and capabilities abroad. All in close collaboration between relevant public and private stakeholders.



LEO Pharma

• Denmark
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Project & Transaction lead, Global Business Development

  • Nov 2015 - Sep 2018

  Copenhagen Area, Capital Region, Denmark Project lead on Region International's Business Development projects. Responsible for idea generation, scouting, pre-evaluation, Due Dilligence, negotiation and final closing.

• Senior Director, Business Evaluation in Global BD

  • Nov 2014 - Oct 2015

  Established and led a strong Business Evaluation team to assess and valuate all BD/M&A opportunities and internal pipeline projects Established cross-LEO BD ressource aliance group for fast and consistent evaluations and bids on licensing and M&A opportunities.

• Director, Portfolio Management, Project Management

  • Oct 2012 - Oct 2014

  • Developed and drove LEOs bi-annual Project & Portfolio review process • Responsible for a change programme called 'Project & Portfolio Excellence'. Objective: increase development speed and processes via clear stage gates, to optimize overall value of pipeline

• Head of Financial Development

  • Jan 2012 - Dec 2012

  Internal consultancy. Ensured delivery on various cross-functional projects by developing and leading a team of seven internal management consultants.



Takeda Pharmaceuticals (formerly Nycomed)

• Switzerland
• Pharmaceutical Manufacturing
• 500 - 600 Employee

• Director Strategic Business Planning, Business Development, Corporate Strategy / M&A

  • Jun 2003 - Aug 2011

  • Developed and managed global strategic business planning process and five-year Strategic Target Plan • Supported CEO/CFO/COO at Business Reviews via various decision support • Generated >€40m EBIT annually by pioneering a corporate strategy process called 'Porfolio of Initiatives' that resulted in 29 improvement projects • Contributed to various M&As including acquisition of Altana Pharma, as well as prepared the exit of Nycomed as a trade sale • Responsible for driving and… Show more • Developed and managed global strategic business planning process and five-year Strategic Target Plan • Supported CEO/CFO/COO at Business Reviews via various decision support • Generated >€40m EBIT annually by pioneering a corporate strategy process called 'Porfolio of Initiatives' that resulted in 29 improvement projects • Contributed to various M&As including acquisition of Altana Pharma, as well as prepared the exit of Nycomed as a trade sale • Responsible for driving and consolidating Nycomeds Annual Business Plan • Initiated and implemented a yearly Project & Portfolio Review process with R&D Show less



Lundbeck

• Denmark
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Head of Strategic Planning, Strategic Marketing

  • Feb 2001 - May 2003

  • Commercial input to Lundbeck's various pipeline projects • Developed pre-marketing plans and positioning on two early stage Parkinson projects • Evaluated in-licensing candidates and contributed to institute new portfolio management function

• Head of Financial Planning & Analysis, Corporate Finance

  • Jan 1999 - Jan 2001

  • Responsible for Lundbeck's Financial Planning cycle, budget and 10 year plan. • Led business analysts delivering various ad hoc tasks and analyses. • Management support to CFO during IPO, investor meeting etc.



Novo Nordisk

• Denmark
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Business Analyst, Corporate Finance

  • Mar 1996 - Dec 1998

  Copenhagen Area, Capital Region, Denmark